Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Expedition Trl
Ste 101
Gettysburg, PA 17325Phone+1 717-334-4033Fax+1 717-334-5599
Education & Training
- Penn State Milton S Hershey Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1988
- UPMC Medical Education (Harrisburg)Residency, Internal Medicine, 1983 - 1986
- University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1983
- Baroda Medical CollegeClass of 1980
Certifications & Licensure
- MD State Medical License 1987 - 2025
- PA State Medical License 1984 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2004 Aug 01
- Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy Start of enrollment: 2006 Feb 01
- Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Start of enrollment: 2011 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsA Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer.Neal Shore, Begoña Mellado, Satish Shah, Ralph Hauke, Dan Costin
Clinical Genitourinary Cancer. 2023-04-01 - 14 citationsRandomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors.Cara Cacioppo, Brian L. Egleston, Dominique Fetzer, Colleen Burke Sands, Syeda A. Raza
Cancer Medicine. 2021-06-08 - 11 citationsA Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.Ramesh K. Ramanathan, Gary W. Thomas, Alok A. Khorana, Satish Shah, Cathy Zhou
Oncology. 2019-01-01
Press Mentions
- Gettysburg Cancer Center Changes NameSeptember 20th, 2022
- OneOncology Platform Continues to Expand with Gettysburg Cancer CenterJune 23rd, 2021
- Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid TumorsMarch 24th, 2021
Research History
- Director of Research23 clinical trials at present1990 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: